. . .

Month: November 2018

29: Idarucizumab for dabigatran reversal, rivaroxaban for PE with active cancer, and an evidence based guideline resource

In this episode I will: 1. Review an article about idarucizumab for dabigatran reversal 2. Answer a drug information question: “Can I use rivaroxaban to treat a pulmonary embolism (PE) in a patient with active cancer?” 3. Share a resource I use that is a collection of evidence based critical care guidelines Lead author:  Charles V. […]